首页> 外文期刊>British journal of ophthalmology >Pars plana vitrectomy with peripheral retinotomy after injection of preoperative intravitreal tissue plasminogen activator: a modified procedure to drain massive subretinal haemorrhage.
【24h】

Pars plana vitrectomy with peripheral retinotomy after injection of preoperative intravitreal tissue plasminogen activator: a modified procedure to drain massive subretinal haemorrhage.

机译:术前玻璃体内组织纤维蛋白溶酶原激活剂注射后的帕斯玻璃体切除术及周边视网膜切开术:一种改良的程序,可排出大量视网膜下出血。

获取原文
获取原文并翻译 | 示例
       

摘要

AIMS: To report outcome of a modified procedure for draining massive subretinal haemorrhages (SRHs). METHODS: The charts of eight consecutive eyes from eight patients with massive SRHs extending to the periphery and involving two or more quadrants with haemorrhagic and bullous retinal detachment were reviewed. Tissue plasminogen activator (tPA) was injected intravitreally 12-24 h preoperatively; vitrectomy was carried out with peripheral retinotomy, drainage of the SRH from the retinotomy using perfluorocarbon liquid and gas tamponade with prone positioning postoperatively. RESULTS: The preoperative visual acuities ranged from light perception to 20/200. Most of the subretinal haematomas moved postoperatively to the vitreous cavity through the peripheral retinotomy using perfluorocarbon liquid. Residual SRHs were drained from the anterior chamber at the bedside after prone positioning overnight. SRH recurred in one eye 14 months postoperatively and was successfully retreated. No other serious complications developed. The final visual acuity improved in seven eyes (range 20/1000-20/60). Polypoidal lesions in choroidal vasculatures were present in three of seven patients. CONCLUSIONS: The technique seems safe and effective for treating massive SRH. However, visual recovery is limited by the underlying macular pathology. Polypoidal choroidal vasculopathy, other than age-related macular degeneration, may be another cause of massive SRHs.
机译:目的:报告改良的引流视网膜下出血(SRH)的程序的结果。方法:回顾了八名SRHs延伸至周围并且涉及出血和大疱性视网膜脱离的象限的四名患者的八只连续眼睛的图表。术前12-24小时玻璃体内注射组织纤溶酶原激活剂(tPA)。玻璃体切除术采用周边视网膜切开术,使用全氟化碳液体和气体填塞器从视网膜切开术引流SRH,术后俯卧。结果:术前视力范围从光线感知到20/200。大部分视网膜下血肿在术后使用全氟化碳液体通过周边视网膜切开术移至玻璃体腔。放置过夜后,残留的SRH从床旁的前房排出。术后14个月,一只眼睛的SRH复发,并成功治愈。没有其他严重的并发症发生。最终的视力在七只眼中得到了改善(范围为20 / 1000-20 / 60)。七名患者中有三名出现脉络膜脉管系统息肉样病变。结论:该技术似乎可安全有效地治疗大量SRH。但是,视觉恢复受到潜在的黄斑病变的限制。除了与年龄相关的黄斑变性外,息肉样脉络膜血管病可能是发生大量SRH的另一原因。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号